CRDL.TO
Price:
$2.74
Market Cap:
$315.85M
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the compan...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-12-20
Stock Exchange
TSX
Ticker
CRDL.TO
According to Cardiol Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -8.14. This represents a change of 66.97% compared to the average of -4.88 of the last 4 quarters.
The mean historical PE Ratio of Cardiol Therapeutics Inc. over the last ten years is -10.11. The current -8.14 PE Ratio has changed 7.95% with respect to the historical average. Over the past ten years (40 quarters), CRDL.TO's PE Ratio was at its highest in in the March 2023 quarter at -1.69. The PE Ratio was at its lowest in in the June 2017 quarter at -53.21.
Average
-10.11
Median
-4.03
Minimum
-56.77
Maximum
-2.50
Discovering the peaks and valleys of Cardiol Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 96.31%
Maximum Annual PE Ratio = -2.50
Minimum Annual Increase = -92.39%
Minimum Annual PE Ratio = -56.77
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -3.36 | -7.40% |
| 2024 | -3.63 | 45.10% |
| 2023 | -2.50 | -34.78% |
| 2022 | -3.83 | -6.22% |
| 2021 | -4.09 | 1.46% |
| 2020 | -4.03 | -52.50% |
| 2019 | -8.48 | 96.31% |
| 2018 | -4.32 | -92.39% |
The current PE Ratio of Cardiol Therapeutics Inc. (CRDL.TO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.16
5-year avg
-3.48
10-year avg
-10.11
Cardiol Therapeutics Inc.’s PE Ratio is greater than Grown Rogue International Inc. (-28.84), less than BioSyent Inc. (18.03), less than Jushi Holdings Inc. (-1.76), less than Cannara Biotech Inc. (17.52), less than Planet 13 Holdings Inc. (-0.75), less than BioNxt Solutions Inc. (-4.60), less than Satellos Bioscience Inc. (-4.99), greater than HLS Therapeutics Inc. (-10.61), less than Vext Science, Inc. (-2.45), less than Zentek Ltd. (-8.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -28.84 | $152.46M | |
| 18.03 | $181.53M | |
| -1.76 | $163.75M | |
| 17.52 | $181.03M | |
| -0.75 | $60.79M | |
| -4.60 | $44.20M | |
| -4.99 | $286.43M | |
| -10.61 | $126.98M | |
| -2.45 | $65.64M | |
| -8.00 | $94.97M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cardiol Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cardiol Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cardiol Therapeutics Inc.'s PE Ratio?
How is the PE Ratio calculated for Cardiol Therapeutics Inc. (CRDL.TO)?
What is the highest PE Ratio for Cardiol Therapeutics Inc. (CRDL.TO)?
What is the 3-year average PE Ratio for Cardiol Therapeutics Inc. (CRDL.TO)?
What is the 5-year average PE Ratio for Cardiol Therapeutics Inc. (CRDL.TO)?
How does the current PE Ratio for Cardiol Therapeutics Inc. (CRDL.TO) compare to its historical average?